InvestSMART

Capitol Health Limited (ASX: CAJ) - Announcements

DELISTED - Current share price for CAJ : $0.385

ASX company news and announcements for Capitol Health Limited (CAJ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Capitol Health Limited (CAJ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Capitol Health Limited (CAJ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Capitol Health Limited (CAJ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Unsecured Note Redemption & New Senior Secured Financing 8 May 2018 10:25AM $0.275 $0.385 risen by 40%
- Appendix 3B - Dividend Reinvestment Plan Issue 3 Apr 2018 11:22AM $0.270 $0.385 risen by 42.59%
- CAJ: Lapse of Takeover Offer for Integral Diagnostics 29 Mar 2018 10:03AM $0.275 $0.385 risen by 40%
- Section 708A Cleansing Notice and Appendix 3B 22 Mar 2018 3:10PM $0.275 $0.385 risen by 40%
- IDX: Lapse of Capitol Health Bid 13 Mar 2018 5:38PM $0.270 $0.385 risen by 42.59%
- No Extension or Increase to the Takeover Offer for Integral 13 Mar 2018 10:23AM $0.280 $0.385 risen by 37.50%
- S&P DJ Indices Announces March Quarterly Rebalance 9 Mar 2018 8:28AM $0.275 $0.385 risen by 40%
- Dividend Reinvestment Plan - Pricing of New Securities 6 Mar 2018 9:32AM $0.270 $0.385 risen by 42.59%
- Update - Dividend/Distribution - CAJ 6 Mar 2018 9:28AM $0.270 $0.385 risen by 42.59%
- IDX: Target's Statement 2 Mar 2018 9:51AM $0.275 $0.385 risen by 40%
- Capitol Off-Market Takeover Offer for Integral Diagnostics 28 Feb 2018 10:51AM $0.270 $0.385 risen by 42.59%
- FY2018 Half Year Results Presentation 27 Feb 2018 1:36PM $0.285 $0.385 risen by 35.09%
- Dividend/Distribution - CAJ 27 Feb 2018 1:30PM $0.285 $0.385 risen by 35.09%
- FY2018 Half Year Results Release 27 Feb 2018 1:25PM $0.285 $0.385 risen by 35.09%
- Appendix 4D and Half Year Report 27 Feb 2018 1:17PM $0.285 $0.385 risen by 35.09%
- IDX: Extension to Due Date for Target's Statement 26 Feb 2018 4:53PM $0.285 $0.385 risen by 35.09%
- 2nd Supplementary Bidder's Statement 16 Feb 2018 5:14PM $0.265 $0.385 risen by 45.28%
- IDX: Letter to Shareholders - Reject CAJ bid 14 Feb 2018 5:09PM $0.260 $0.385 risen by 48.08%
- Notice of despatch of Capitol bidder's statement 14 Feb 2018 4:12PM $0.260 $0.385 risen by 48.08%
- Off-Market Takeover Offer for IDX Opens Today 14 Feb 2018 12:21PM $0.260 $0.385 risen by 48.08%
- Completion of Radiology Tasmania Group Acquisition 1 Feb 2018 2:23PM $0.280 $0.385 risen by 37.50%
- IDX: Integral Diagnostics Update-Capitol Health Takeover Bid 1 Feb 2018 1:11PM $0.275 $0.385 risen by 40%
- Update on takeover bid for Integral 31 Jan 2018 6:09PM $0.270 $0.385 risen by 42.59%
- IDX: Supplementary Bidder's Statement 31 Jan 2018 5:38PM $0.270 $0.385 risen by 42.59%
- IDX: Replacement Bidder's Statement 31 Jan 2018 5:37PM $0.270 $0.385 risen by 42.59%

501 - 525 of 756 results

Page 21 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.